94 related articles for article (PubMed ID: 7353775)
21. A comparative analysis of pancreas cyst fluid CEA and histology with DNA mutational analysis in the detection of mucin producing or malignant cysts.
Sreenarasimhaiah J; Lara LF; Jazrawi SF; Barnett CC; Tang SJ
JOP; 2009 Mar; 10(2):163-8. PubMed ID: 19287110
[TBL] [Abstract][Full Text] [Related]
22. [CEA determination in aspired fluid of cystic ovarian tumors and ovarian cysts and in ascites and serum samples of patients with ovarian tumors].
Kunze M; Büttner HH; Strache RR; Voss P; Briese V; Schrodt U
Zentralbl Gynakol; 1988; 110(16):1006-12. PubMed ID: 3188713
[TBL] [Abstract][Full Text] [Related]
23. Are serum and biliary carcinoembryonic antigen and carbohydrate antigen19-9 determinations reliable for differentiation between benign and malignant biliary disease?
Akdoğan M; Parlak E; Kayhan B; Balk M; Saydam G; Sahin B
Turk J Gastroenterol; 2003 Sep; 14(3):181-4. PubMed ID: 14655062
[TBL] [Abstract][Full Text] [Related]
24. Serum levels of carcinoembryonic antigen and a tumor-extracted carcinoembryonic antigen-related antigen in cancer patients.
Shively JE; Spayth V; Chang FF; Metter GE; Klein L; Presant CA; Todd CW
Cancer Res; 1982 Jun; 42(6):2506-13. PubMed ID: 7074626
[TBL] [Abstract][Full Text] [Related]
25. The use of serum carcinoembryonic antigen to assess therapeutic response in locally advanced and metastatic breast cancer: a prospective study with external review.
Williams MR; Turkes A; Pearson D; Twining P; Griffiths K; Blamey RW
Eur J Surg Oncol; 1988 Oct; 14(5):417-22. PubMed ID: 3181446
[TBL] [Abstract][Full Text] [Related]
26. Simultaneous assays of cancer associated antigens in benign and malignant breast diseases.
Franchimont P; Zangerle PF; Hendrick JC; Reuter A; Colin C
Cancer; 1977 Jun; 39(6 Suppl):2806-12. PubMed ID: 68808
[No Abstract] [Full Text] [Related]
27. A study of cyst fluid and plasma carcinoembryonic antigen in patients with cystic ovarian neoplasms.
van Nagell JR; Pletsch QA; Goldenberg DM
Cancer Res; 1975 Jun; 35(6):1433-7. PubMed ID: 805659
[TBL] [Abstract][Full Text] [Related]
28. Detection of tumor markers including carcinoembryonic antigen, APC, and cyclin D2 in fine-needle aspiration fluid of breast.
Lee A; Kim Y; Han K; Kang CS; Jeon HM; Shim SI
Arch Pathol Lab Med; 2004 Nov; 128(11):1251-6. PubMed ID: 15508191
[TBL] [Abstract][Full Text] [Related]
29. Clinical evaluation of an immunoradiometric assay for CA15-3 antigen associated with human mammary carcinomas: comparison with carcinoembryonic antigen.
Fujino N; Haga Y; Sakamoto K; Egami H; Kimura M; Nishimura R; Akagi M
Jpn J Clin Oncol; 1986 Dec; 16(4):335-46. PubMed ID: 3467106
[TBL] [Abstract][Full Text] [Related]
30. [Determination of the carcinoembryonic antigen (CEA) for predicting the success of therapy in metastatic breast cancer].
Krieger G; Wander HE; Prangen M; Bandlow G; Beyer JH; Nagel GA
Dtsch Med Wochenschr; 1983 Apr; 108(16):610-4. PubMed ID: 6839982
[TBL] [Abstract][Full Text] [Related]
31. Nipple aspirate fluid collection, related factors and relationship between carcinoembryonic antigen in nipple aspirate fluid and breast diseases in women in Harbin, PRC.
Zhao YS; Pang D; Wang F; Xue YW; Gao DN; Li H; Li K; Wang BY; Wang D; Li HY
Cancer Epidemiol Biomarkers Prev; 2009 Mar; 18(3):732-8. PubMed ID: 19273481
[TBL] [Abstract][Full Text] [Related]
32. [Comparative study of carcino-embryonic antigen and beta2-microglobulin. Methodological study and clinical interpretation (author's transl)].
Depierre A; Kadouche J; Chamagne AM; Najean Y
Pathol Biol (Paris); 1978 Sep; 26(6):341-2. PubMed ID: 83578
[TBL] [Abstract][Full Text] [Related]
33. Serial carcinoembryonic antigen (CEA) determinations in the management of metastatic breast cancer.
Lamerz R; Leonhardt A; Ehrhart H; von Lieven H
Oncodev Biol Med; 1980; 1(2):123-35. PubMed ID: 7279699
[TBL] [Abstract][Full Text] [Related]
34. Presence of elevated carcinoembryonic antigen on absorbent disks applied to nipple area of breast carcinoma patients.
Imayama S; Mori M; Ueo H; Nanbara S; Adachi Y; Mimori K; Shimozono Y; Hori Y; Sugimachi K
Cancer; 1996 Sep; 78(6):1229-34. PubMed ID: 8826944
[TBL] [Abstract][Full Text] [Related]
35. CEA positivity in tissue and sera of patients with benign breast lesions.
Wittekind C; Von Kleist S; Sandritter W
Oncodev Biol Med; 1981; 2(6):381-90. PubMed ID: 7346797
[TBL] [Abstract][Full Text] [Related]
36. Diagnostic significance of carcinoembryonic antigen levels in serous effusions. Correlation with cytology.
Whiteside TL; Dekker A
Acta Cytol; 1979; 23(6):443-8. PubMed ID: 295160
[TBL] [Abstract][Full Text] [Related]
37. [Clinical evaluation of serum CA-50 measurement in breast diseases --relation to the progress of breast cancer].
Shiga T; Kawauchi A; Kamiya K; Ishii J; Uzawa R; Gomi K
Rinsho Byori; 1986 Nov; 34(11):1339-45. PubMed ID: 3469447
[No Abstract] [Full Text] [Related]
38. The biological and clinical significance of tumor markers in tissue extracts.
Castelli M; Sega FM; Sciarretta F; Casale V; Coloni F; Sega E
Cancer Detect Prev; 1983; 6(1-2):61-6. PubMed ID: 6883394
[TBL] [Abstract][Full Text] [Related]
39. Serial carcinoembryonic antigen (CEA) determinations in the management of patients with breast cancer.
Staab HJ; Ahlemann LM; Koch HL; Anderer FA
Oncodev Biol Med; 1980; 1(3):151-60. PubMed ID: 7279702
[TBL] [Abstract][Full Text] [Related]
40. Serum antibody in patients with mammary disease.
Humphrey LJ; Estes NC; Morse PA; Jewell WR; Boudet RA; Hudson MJ
Cancer; 1974 Oct; 34(4 Suppl):suppl:1516-20. PubMed ID: 4214083
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
